Abstract: The present invention relates to a solid pressed air freshener and odor neutralizer composition which can include greater than 10% fragrance. The air freshener comprises a fragrance; preferably the fragrance is impregnated within a water soluble substrate made from a foamed vegetable starch, a surfactant and a solidifier. The solid formulations break down easily in the presence of water and may be sprayed, within the area to be freshened.

Abstract: Provided is an information processing apparatus that is worn on a user's body for use. The information processing apparatus includes a sensor, a communication section, a control section, a power supply section, a housing section, a sticking section, and a sticking sensor. The control section controls the sensor and the communication section. The housing section accommodates the sensor, the communication section, the control section, and the power supply section. The sticking section fastens the housing section to the user. The sticking sensor detects a state of sticking between the user and the housing on the sticking section. The control section wirelessly sends a given signal to external equipment via the communication section in response to detection, by the sticking sensor, of the fact that the sticking section has peeled off from the user or is just about to peel off from the user.

Abstract: The present invention relates to an activated carbon sheet, and particularly relates to an activated carbon sheet for air purification comprising activated carbon, which is suitable for removing volatile organic compounds in the passenger compartment of an automobile or the like. An object of the present invention is to provide a sheet that is excellent in toluene adsorption capacity and flame retardancy. An activated carbon sheet for air purification comprising an activated carbon fiber, granular or powdered activated carbon, and a fibrillated fiber, wherein a mass (g/m2) of the activated carbon fiber is 5 g/m2 or more, a pressure loss as measured by a method set forth below is 150 Pa or less, and a burn distance as measured by the FMVSS 302 burning test is 51 mm or less: <pressure loss test method> the method is conducted in accordance with JIS B 9927:1999 “Appendix (Standard) Cleanroom—Air filters—Test methods”, 3.

Abstract: A method for manufacturing a medical tape includes: applying a solution polymer serving as an elastic base member portion having an elastic function to an upper layer of a film forming base portion having an inelastic function to form a film of the solution polymer; laminating an adhesion portion having a function to apply and hold the elastic base member portion to a skin on an upper layer of the elastic base member portion, and laminating a release portion having a function to protect the adhesion portion on an upper layer of the adhesion portion; peeling and removing the film forming base portion from the elastic base member portion to obtain the elastic base member portion in a state where a residual shrink force generated by a forming shrinkage of the solution polymer is reduced and to obtain a three-layer structure consisting of the elastic base member portion.

Abstract: The present invention relates to water soluble and completely absorbable and/or physiologically degradable hemostatic compositions having a wax or wax-like base effective for tamponade hemostasis of bone or cartilage.

Abstract: The present invention is directed to bioresorbable polymers to be used as bone and tissue adhesives. The present invention is also directed to the synthesis of bioresorbable polymeric molecules bearing adhesive moieties and the use of such compounds in methods to glue and stabilize fractured bones and damaged tissues. The present invention is also directed to the use of such compounds as adhesive sealants for applications in wound care. The present invention is also directed to the use of such compounds as biodegradable ink for applications in tissue engineering and 3D printing. The present invention also relates to the use of such compounds as drug delivery platforms.

Abstract: An autologous bone graft substitute composition for inducing new bone formation, promoting bone growth and treating bone defects. The composition includes autologous blood; one or more analogs of an osteogenic bone morphogenetic protein selected from BMP-6, BMP-2, BMP-7, BMP-4, BMP-5, BMP-8, BMP-9, BMP-12, and BMP-13, and combinations thereof in a range of from 2 to 1000 ?g per ml of autologous blood; and hydroxyapatite, tri-calcium phosphate, or a mixture thereof as a compression resistant matrix, the compression resistant matrix being provided in the form of particles having a particle size in a range of from above 74 to 8000 ?m. Preferably, a ratio between the compression resistant matrix and the autologous blood coagulum is from 50 to 500 mg of the compression resistant matrix per mL of the autologous blood coagulum.

Abstract: Embodiments of the invention provide compositions including bio degradable polymers, medical implants fabricated from these compositions and methods of using such implants. Many embodiments provide medical implants comprising a first polymer backbone having a first rate of biodegradation and a second polymer backbone having a second rate of biodegradation faster than the first rate. In some embodiments, the second backbone is configured to be replaced by a natural tissue layer. The first backbone provides a scaffold for the implant while the second backbone degrades. This scaffold can enhance mechanical properties of the implant including various aspects of mechanical strength such as tensile, bending, hoop and yield strength; and elasticity. The scaffold also serves to maintain a minimum level of structural support of the implant during the period of degradation of the second backbone or for the entire life of the implant so that the implant does not mechanically fail.

Abstract: The present disclosure relates to injectable and expandable compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely to fill and/or fuse a tissue defect. The present disclosure relates to compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely for bone tissue defect filling/fusion. The design of extendable and expandable compositions for bone fusion is one of the most challenging fields in the intersection of polymer and biomedical engineering. An aspect of the present disclosure relates to an injectable expandable composition for use in medicine, veterinary or cosmetic, comprising a polycaprolactone particle filler; a polydopamine adhesive bound to said filler; a polymethacrylic acid plasticizer bound to said polydopamine adhesive.

Abstract: Various aspects described herein relate to compositions comprising silk fibroin particles and methods of using the same, as well as devices and methods of delivering such compositions. The compositions described herein are suitable for injection into a site of defect in a soft tissue to provide bulking and/or augmentation effect to the soft tissue.

Abstract: A barrier of a vacuum pump prevents contamination from entering a vacuum pump air line. The barrier separates parts of the pump and is moveable between an initial state and a distended state. The barrier is assembled within the pump with a pre-load. When the vacuum source is applied to the barrier, the barrier achieves a distended state and when the vacuum source is released, the barrier incrementally self returns to an initial state. The geometry and material construction of the barrier, along with the pre-load, assists in returning the barrier on its own to the initial state from the distended state.

Abstract: The present invention relates to an apparatus (2) comprising a connector (4), a baby bottle (6) which can be coupled thereto having a bottle body (8) and a bottle base (10), and a sensor unit (34) arranged in the bottle base (10) for determining the filling quantity of milk in the baby bottle (6). An object of the present invention is to improve handling and maintenance of the apparatus, as well as determining the content quantity. It is characterized in that the bottle base (10) is releasably attachable to the bottle body (8).

Abstract: A breast shield for a breast pump for expressing human breast milk comprises a rigid base part (1) with a tubular connection piece (10) and with a funnel (11), which is integrally moulded in one piece thereon and widens away from the connection piece (10), for receiving a breast. The breast shield additionally comprises a flexible collar (2) which is arranged on the funnel (11) at an end of the funnel (11) remote from the connection piece (10) and which is realized to be placed onto the mother's breast. The named end of the funnel (11) forms a first contact surface (12) and an end of the collar (2) which faces the funnel (11) forms a second contact surface (22) and they both adjoin one another in an obtuse manner in a circumferential connecting joint (4), wherein the connecting joint is a butt joint.

Abstract: An interface device between external equipment and at least a venous tube for transferring fluid to a patient, the interface device having at least a first port adapted to be connected to an outlet port of the external equipment; and a venous port carried by a stator of the interface device in order to inject the fluid into the venous tube. The interface device includes a third port, the first port and the third port being carried by a movable assembly that is movable relative to the stator, the interface device being arranged to pass from any one of its configurations to another one of its configurations by the movable assembly moving relative to the stator.

Abstract: A system for supporting the blood gas exchange by means of mechanical ventilation and extracorporeal blood gas exchange comprises a ventilation device for mechanical ventilation of the lungs of a patient, and an ECLS device for the extracorporeal blood gas exchange, wherein the ventilation system is designed to perform mechanical respiratory support by the ventilation device on the one hand and an extracorporeal blood gas exchange by the ECLS device on the other hand in coordinated, automated manner in order to support the gas exchange in the blood circulation of the patient, wherein the ECLS device sets a level of the extracorporeal blood gas exchange, and the ventilation device, on the basis of the level of the extracorporeal blood gas exchange set by the ECLS device, adjusts in automated manner to a level of the mechanical respiratory support.

Abstract: A blood purification system is provided that is capable of effectively utilizing accumulated histories stored during blood purification treatment and that helps take a quick and appropriate action in response to a particular incident that occurs unsteadily. In a blood purification system, a history stored in a storage device includes particular incidents having occurred unsteadily in blood purification treatment. The blood purification system includes an extracting device capable of searching the histories accumulated in the storage device and extracting a desired one of the particular incidents, a calculating device capable of calculating a time when the particular incident extracted by the extracting device occurs a predetermined or more number of times as a frequent-occurrence time slot, and a display control device capable of displaying the frequent-occurrence time slot calculated by the calculating device on a display during a current session of blood purification treatment.

Abstract: A reverse osmosis (RO) system is described that is connectable to a dialysis machine and is capable of using heated purified water to clean and disinfect an external connection section or portion disposed between the RO system and the dialysis unit (or any other external heat tolerant device) without forming a closed loop system between both systems before and during a heat forward process. This can be accomplished without the need for direct/indirect or wired/wireless communication with the dialysis unit or the need to introduce a chemical cleaner or process that would require further rinsing after chemical disinfection.

Abstract: In some embodiments, an apparatus for providing negative pressure wound therapy to multiple wounds includes a negative pressure source configured to couple via a plurality of fluid flow paths to a plurality of wound dressings. The plurality of flow paths includes a plurality of calibrated leaks. The apparatus also includes a controller configured to determine a total rate of flow in the plurality of fluid flow paths and compare the total rate of flow to a plurality of thresholds associated with the plurality of calibrated leaks to determine one or more operating conditions, such as a blockage in one or more of the plurality of flow paths. An indication of the operating condition can be provided.

Abstract: A laparoscopic anti-clogging device suitable for abdominal surgeries whose main function is to overcome the deficiencies caused by the clogging of a suction tool used in suction irrigation. More specifically an improved suction unclogging means used in Laparoscopic Suction Irrigator Systems (LSIS) that is used in the removal of bodily fluids, exudate and or bodily materials from the abdomen of a patient, allowing suction of a high-volume fluid in deep cavities and prevents interrupting fluid flow due to tissues clogging the device, and having the ability of being modified intra-abdominally to then focus all of its vacuum force on the distal opening, thereby facilitating blood clot busting and suction of solidified fluids as well as directed irrigation.

Abstract: Embodiments of negative pressure wound therapy systems, apparatuses, and methods for operating the systems and apparatuses are disclosed. In some embodiments, a medical device is configured to detect an identity of a patient-contacting disposable connected to the medical device. The medical device automatically modifies one or more operational parameters of the medical device based on the identity of the patient-contacting disposable connected to the medical device. The medical device can include a user interface and modify automatically available selections in the user interface based on the identity of the patient-contacting disposable connected to the medical device.

Abstract: Packaging for an injection device, the packaging including a channel extending longitudinally to accommodate the injection device, the channel including a longitudinal wall adjoining a base wall; a handling recess extending laterally and formed through the longitudinal wall, a positioning rib extending longitudinally and protruding from the base wall into the channel for insertion into a positioning recess of the injection device, the positioning rib arranged offset laterally from the recess and extending in a longitudinal field defined by the handling recess.

Abstract: A container (10) for storing new and used pen needles (20,30), the container (10) comprising a housing (12) including a first compartment (50) configured to store one or mom new pen needles (20), and a second compartment (52) configured to store one or more used pen needles (30), wherein the first and second compartments (50,52) are inversely adjustable in size to accommodate various combinations of new and used pen needles (20, 30).

Abstract: An infusion system for subcutaneous delivery of a fluid to a subject is disclosed. The infusion system comprises a source of a fluid; a fluid delivery system; a first fluid conduit in fluid communication with the source of the fluid and the fluid delivery system; a fluid injection device configured to be inserted into the skin of a subject for delivering the fluid to the subject; a second fluid conduit in fluid communication with the fluid delivery system and the fluid injection device; and a support frame attached to the source of the fluid and the fluid delivery system, wherein the support frame is configured to mount the source of the fluid and the fluid delivery system on a region of a head of the subject. The fluid delivery system moves the fluid from the source of the fluid, through the first fluid conduit, through the second fluid conduit, and through the fluid injection device.

Abstract: A fluid infusion system includes a housing configured to be adhesively coupled to an anatomy of the user. The housing comprises a communication device configured to wirelessly communicate a physiological characteristic to a communication component of a fluid infusion device. The fluid infusion system includes a fluid flow path from the fluid infusion device into the anatomy of the user, and the fluid flow path is configured to extend from the housing for insertion into the anatomy of the user.

Abstract: Embodiments herein describe tools, instruments and methods for aseptic loading, dispensing and/or delivering cells into an implantable device and aseptically and selectively sealing a device inside a sterile package as well as and storing and preparing for shipment the cell-filled device.

Abstract: A fluid delivery device comprises a hydraulic pump chamber having a hydraulic fluid. A fluid reservoir is coupled to the hydraulic pump chamber and is configured to contain a fluid deliverable to a patient. A first actuator is coupled to the hydraulic pump chamber and is configured to pressurize the hydraulic pump chamber and configured to transfer energy through the hydraulic pump chamber to the fluid reservoir. A second actuator is coupled to the hydraulic pump chamber and is configured to pressurize the hydraulic pump chamber and configured to transfer energy through the hydraulic pump chamber to the fluid reservoir.

Abstract: An injector is configured to receive therein a cartridge containing a substance to be dispensed. The injector includes an injector housing and an injector door movably mounted to the injector housing between a fully closed position and a fully open position. The injector door is initially locked in an at least partially closed position preventing insertion of the cartridge into the injector. The injector further includes a controller configured to conduct an initial self-test on operability of at least one component of the injector. The self-test has a single pass or fail outcome, wherein the injector door is unlocked and enabled to be moved into the fully open position, to enable insertion of the cartridge into the injector, solely upon achievement of the self-test pass outcome.

Abstract: An apparatus for the uninterrupted administration of fluid to an animal body during clean blood collections is disclosed. Embodiments include an intravenous device defining a first fluid channel, wherein the first fluid channel is configured to selectively transport IV fluid to an animal body and draw a bodily fluid from the body, and a connection member configured to connect to a catheter to the first fluid channel and defining a concave distal end. A second fluid channel continuously provides IV fluid to a lumen coaxially located within the catheter. The concave surface is shaped to create a fluid flow pattern that quickly and completely removes residual bodily fluid remaining at the concave distal end. Embodiments include a concave surface defining an asymmetric funnel shape, a vertex of which is centered on the first fluid channel.

Abstract: A system and method removing air from a reservoir, the system comprising the reservoir that carries a medicament, a first pump connected to the reservoir that draws the medicament out of the reservoir, an air removal device connected to the first pump that releases air from the medicament, and a second pump connected to the air removal device that delivers the medicament.

Abstract: A method may include receiving, from a volume meter at a pump configured to deliver medication to a patient, data indicative of a volume of a medication present in a syringe inserted in the pump. A first counter may be updated, based on the data, in response to the medication being delivered to the patient as a first dose type. A second counter may be updated, based on the data, in response to the medication being delivered to the patient as a second dose type. The volume of the medication delivered to the patient may be determined based on the first counter and/or the second counter. An electronic alert may be sent to a mobile device in response to one or more anomalies being present in the volume of the medication delivered to the patient. Related methods and articles of manufacture, including apparatuses and computer program products, are also disclosed.

Abstract: An infusion pump (18) for delivery of a fluid is disclosed. The infusion pump allows a user to selectively control a flow rate of a fluid and includes a spike member (26) that is connectable to an injection port of an intravenous fluid container (12).

Abstract: An injection device comprising a housing in which can be mounted a syringe comprising a barrel for holding a volume of medicament, a needle at one end of the barrel and a plunger axially-moveable in the barrel to a forwardmost position, the injection device further comprising a syringe support means for supporting the barrel at an axial location at or forward of the forwardmost position of the plunger and having a reaction surface for the syringe, whereby in use said reaction surface provides an axial compressive force on said barrel when a forward axial force is applied to the plunger.

Abstract: The disclosure relates to a drug delivery device, comprising: an outer needle sleeve; a cartridge containing a dosage of a medicament and sealed with a sealing element that is arranged across an open distal end of the cartridge; a cartridge carrier adapted to hold the cartridge; a needle hub adapted to hold a double ended hollow needle; an inner needle sleeve arranged between the needle hub and the cartridge carrier; a removable cap coupled to the inner needle sleeve and adapted to cover and seal the needle; and a first locking mechanism adapted to lock the inner needle sleeve against axial movement in the proximal direction with respect to the cartridge carrier in an initial state, wherein in the initial state, the needle is spaced from the cartridge in the distal direction, and wherein the first locking mechanism is releasable by a rotational movement of the cap with respect to the outer needle sleeve.

Abstract: Provided is a fluid wicking tip. The fluid wicking tip includes a plurality of drip flanges arranged to wick fluid between narrow spaces defined between any two drip flanges. The narrow spaces are dimensioned to facilitate wicking by capillary action. Also provided is a syringe that includes the fluid wicking tip. Also provided is a modular syringe system that includes a syringe and a sleeve configured to be slidably disposed over the syringe.

Abstract: A part of a device for injecting a liquid product having an end sleeve and a syringe support which is able to move with respect to the end sleeve. The syringe support is designed to bear an injection syringe fitted with a removable protective cap. A deformable ring is kinematically connected to the syringe support. This ring can be deformed elastically between a configuration which is designed to axially immobilize the injection syringe in the syringe support, and a configuration designed to allow the protective cap to pass through the deformable ring.

Abstract: Syringes are described herein. A syringe includes a syringe body, a first plunger, a biasing member, and a retention member. The syringe body defines a syringe cavity and a syringe port, wherein the syringe port is in fluid communication with the syringe cavity. The first plunger comprises a first plunger shaft extending from the first plunger, the first plunger disposed within the syringe cavity and defining a first chamber in the syringe cavity, wherein the first chamber is in fluid communication with the syringe port. The biasing member is coupled to the first plunger shaft, wherein the biasing member urges the first plunger to advance toward the syringe port. The retention mechanism prevents the biasing member from advancing the first plunger in an engaged position and permits the biasing member to advance the first plunger in a released position.

Abstract: A drive assembly includes a drive ribbon that can be retracted and extended. The retracted ribbon defines a spiral and the extended ribbon defines a helix. The drive ribbon is incrementally moveable between the retracted spiral configuration and extended helical configuration to move a piston within a container. A medical delivery device for advancing a piston in a medicament container to expel a medicament can include such drive assembly.

Abstract: The present disclosure relates to medicament injection devices. An injection device includes: a movable dosage programming component comprising a rotary encoder system having a predefined angular periodicity, a sensor arrangement including a first optical sensor configured to detect movement of the movable dosage programming component relative to the sensor arrangement during dosing of a medicament, wherein the first optical sensor is configured to operate in a strobe-sampling mode at a first frequency, a second optical sensor configured to detect movement of the rotary encoder system relative to the second optical sensor wherein the second optical sensor is configured to operate in a strobe-sampling mode at a second frequency lower than the first frequency, and a processor arrangement configured to, based on the detected movement, determine a medicament dosage administered by the injection device.

Abstract: A medication delivery device and/or dosing mechanisms suitable for use in medication delivery devices, in particular in pen-type injectors, preferably having a dose setting system and a drive device enabling the administration of a medicinal product from a single- or multi-dose medication cartridge.

Abstract: An injector includes an injector housing, an activation button assembly movably mounted to the injector housing and operatively connected to the injection needle, and a cartridge door movably mounted to the injector housing between an open position and a closed position. A deflectable interference member engaging the rear end flange of the cartridge has a resting position configured to limit an insertion depth of a cartridge into an interior channel of the cartridge door to a sealed position, wherein the cartridge piercing needle does not fully penetrate a pierceable septum of the cartridge. The cartridge door includes an interior channel having a cartridge mounted therein. The cartridge includes a substance to be dispensed. The substance includes an anti-C5 antibody or antigen binding fragment thereof, and optionally further includes a recombinant human hyaluronidase enzyme. A method of treating a complement associated condition using an injector thereof.

Abstract: Drug delivery safety devices having trigger activation systems activated by pressure against the skin of a patient and which automatically shield the needle after withdrawing the needle from the skin of the patient.

Abstract: A cannula hub includes a shaft mount segment and a cannula coupling segment. A set of coupling nubbins radially extend from the outer surface of the cannula coupling segment. The coupling nubbins are aligned with one another along a helical cannula coupling pathway on the outer surface and are adapted to be received within a cooperative helical groove on a transfer vessel. The coupling nubbins have a protrusion projection distance that is greater than the depth of the groove. When a sufficient rotational force is applied to the cannula hub, the coupling nubbins score the inside face of the groove which increases the groove depth and enables the coupling nubbins to advance along the groove while forming a tight compression fit of the coupling nubbins within the groove.

Abstract: Drug supply units are disclosed which comprise substrates having a plurality of holes formed therein.

Abstract: The presently disclosed embodiments relate to insufflation and irrigation conduits for vessel harvesting systems and methods of their use. In particular, the present disclosure relates to a system having a combined cabling for providing gases, liquids, and/or electrical power to an attached medical device and method of use.

Abstract: This invention provides a budesonide/formoterol dry powder inhaler (10) comprising: a reservoir (14) containing a dry powder medicament and an arrangement for delivering a metered dose of the medicament from the reservoir; a cyclone deagglomerator (10?) for breaking up agglomerates of the dry powder medicament; a delivery passageway (34) for directing an inhalation-induced air flow through a mouthpiece (24), the delivery passageway extending to the metered dose of medicament, wherein the medicament comprises micronised formoterol fumarate, micronised budesonide and a lactose carrier, the lactose carrier having a particle size distribution of d10=20-65 ?m, d50=80-120 ?m, d90=130-180 ?m and <10 ?m=<10%.

Abstract: A nebulizer for a fluid, includes a container containing the fluid; a housing part which can be detached from the nebulizer for replacing the container; an inner part; a retaining element connected with and not detachable from the inner part, where the housing part is releasable fixed to the inner part by the retaining element; a delivery mechanism for dispensing the fluid; a manually depressible actuator member, which is a separate part from the retaining element and acts on the retaining element, and wherein the actuator member is depressed to elastically deform or flex the retaining element to allow detachment of the housing part.

Abstract: A measurement device and a method for monitoring a condition of a patient. The measurement device includes: a gas-guide apparatus, connected between an medical gas provider and a patient and configured to deliver medical gas from the medical gas provider to the patient; and at least one sensing apparatus, placed on an outer surface of the gas-guide apparatus and configured to detect real-time measurement data of the medical gas passing through the gas-guide apparatus. In this way, the at least one sensing apparatus is placed on the outer surface of the gas-guide apparatus, since the measurement data is a relative value which indicates a change of internal environment of the gas-guide apparatus, this can also avoid a problem of contamination compared with setting a sensor inside a respiratory device, thus improving the security of the measurement.

Abstract: A breathing assistance apparatus is configured with features that improve serviceability of the apparatus. The apparatus can include animations to provide instruction regarding correcting easily-identified fault conditions and to provide instruction regarding routine maintenance routines. The apparatus also can be configured with top level control menus that are obscured in a manner to limit manipulation of the top level control elements by unauthorized users.

Abstract: A respiratory system, primarily to provide a mechanical insufflation/exsufflation therapy, may include a first pressure generating source, a second pressure generating source and a primary valve to switch between insufflation/positive pressure flow and exsufflation/negative pressure flow, and to generate oscillations alongside either of these cycles. The respiratory system can optionally employ a secondary valve either on a fluidic path of the first pressure generating source or on a fluidic path of the second pressure generating source. An interfacing assembly acts as a fluidic conduit between the pressure generating sources and the patient. A control unit is configured to generate required pressurized flow and oscillations as per the user settings. The aforesaid valves can be manipulated into multiple orientations/positions, which are aligned and/or adjusted with respect to the respective pressure generating sources as per the therapy requirements.

Abstract: The present invention relates to a plurality of ventilation devices, to ventilation devices having visualization apparatuses, and to methods for operating the ventilation devices. The intent is to minimize the energy input into the at least one airway of a patient as a result of the ventilation.